Clinical trial

Evaluation of an Oxygen Enhanced Magnetic Resonance Imaging Method on Patients With Chronic Obstructive Pulmonary Disease During 8 Weeks Treatment With Either Symbicort Turbuhaler or Oxis Turbuhaler

NCT01257048

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Formoterol Turbuhaler Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Budesonide/Formoterol Turbuhaler Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Formoterol Turbuhaler Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Evaluation of an Oxygen Enhanced Magnetic Resonance Imaging Method on Patients With Chronic Obstructive Pulmonary Disease During 8 Weeks Treatment With Either Symbicort Turbuhaler or Oxis Turbuhaler

Design: INTERVENTIONAL · Status: COMPLETED · Phase: EARLY_PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-08-01

PhaseEARLY_PHASE1

Conditions

COPD Method Evaluationunresolved

Chronic Obstructive Pulmonary Disease Method Evaluationunresolved

Interventions

Formoterol TurbuhalerDRUG

Budesonide/Formoterol TurbuhalerDRUG

Formoterol TurbuhalerDRUG

Sponsors & collaborators

AstraZenecalead sponsor

Mapped research locations

ManchesterUnited Kingdom1 LundSweden1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01257048 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.